Till startsida
To content Read more about how we use cookies on gu.se


  • Roles and duties in war and peace in focus for visiting professor Boffard

    [11 Dec 2019] During one of Kenneth Boffard¿s first assignments, as a doctor in Europe, at a hospital in Birmingham, he had to manage the casualties of an IRA bombing. Some 40 years later, as Visiting Professor at Sahlgrenska Academy, he is working with members of the Department of Surgery to develop a training program that meets the needs of health professionals working in crisis and war-torn countries abroad. We have met the recognized trauma expert Professor Kenneth (¿Ken¿) Boffard for an interview.

  • Important to be open to discussing sex with young cancer survivors

    [19 Jun 2018] Feeling unattractive and dissatisfied with their sexual ability - that is reality for many teenage and young adult cancer survivors. Research from Sahlgrenska Academy now gives a voice to a group that often has a difficult journey back to a normal life.

  • Needle release optimal treatment for Viking disease

    [19 Jun 2018] The various treatments for ¿Viking disease¿ are coming under closer scrutiny. Research shows that crooked fingers can be straightened just as well with needle release as with the substantially more expensive commonly used drug.

  • Education and income determine whether women participate in cervical screening

    [11 Jan 2018] The impression that foreign-born women in Sweden more often are excluded from gynecological cancer screening needs to be reconsidered. A study from Sahlgrenska Academy, published in the journal PLOS One, makes it clear that foreign-born women participate to the same extent as women born in Sweden with a corresponding educational level and income.

  • Clear effect of new medicine against severe muscle disease

    [6 Nov 2017] A new medicine against the severe muscle disease spinal muscular atrophy proved to have such good effect on small children that an international study was discontinued early. A team at Sahlgrenska Academy is in charge of the Swedish part of the trial presented in the New England Journal of Medicine (NEJM).

  • Promising drugs for the most serious complications in premature children

    [11 Jul 2016] A new drug based on research at the University of Gothenburg seems to be able to prevent both stroke and severe lung disease in children born extremely prematurely. In a smaller first study in which the drug was administered to premature children, the risk of these complications was cut in half.

  • Why is osteoarthritis more common among athletes?

    [3 Nov 2015] Osteoarthritis and reduced range of motion in the hip and groin are more common among athletes and other people who engage in strenuous physical activity. The cause may be microscopic injuries due to high load on the hips and subsequent joint changes. A PhD thesis at Sahlgrenska Academy studied elite soccer and hockey players.

  • 121 million from The Swedish Research Council in Medicine and Health

    [3 Nov 2015] The University of Gothenburg gets 121 million SEK in grants from the Swedish Research Council's call in medicine and health. It's an improvement compared to last year.

  • Joint Japan Sweden Radioecology Workshop, 2 Sep

    [28 Aug 2015] On September 2 there will be a workshop about research within radioecology at the Department of Radiation Physics, Sahlgrenska University Hospital. This is a joint effort between Japanese and Swedish researchers and presentations will be held from 08:30 to 17:00

  • New model for identifying total hip replacement candidates

    [21 May 2015] Researchers at Sahlgrenska Academy have designed a new model to help doctors and patients decide whether or not to proceed with total hip replacement surgery. The researchers have also surveyed patient wellbeing after surgery: patients with high education achieve greater outcome scores, while those with antidepressant prescriptions do not.

Fler nyheter

Page Manager: Katarina Olinder Eriksson|Last update: 10/26/2007

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?